Strong Support

For people with type 2 diabetes and kidney problems who are on certain blood pressure medicines, taking a weekly semaglutide shot might lower their chance of dying from heart issues by almost a third over about 3 years.

82
Pro
0
Against

Evidence from Studies

Supporting (1)

82

Community contributions welcome

The study tested the same drug, dose, and type of patients as described in the claim, and found that it reduced heart-related deaths by 29%, just like the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.